Hoshino M, Shimoi T, Yamanaka T, Kitadai R, et al. Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer. Breast Cancer 2025 Jul 28. doi: 10.1007/s12282-025-01747.
PMID: 40721911